Costs of Robotic-Assisted Versus Traditional Laparoscopy in Endometrial Cancer

Abstract

According to this study, robotic-assisted laparoscopy is 37% more expensive than traditional laparoscopy in the treatment of endometrial cancer. The cost difference is mainly explained by amortization of the robot and its instrumentation.

Laparotomic versus robotic surgery in elderly patients with endometrial cancer: A systematic review and meta‐analysis

“…The median actual costs of the robotic surgery are 35% higher per patient than the costs related to traditional laparoscopy 40,41 . Amortization of the robot console and costs involved with robot instrumentation are the major determinants of the incremental costs related to robotic surgery 42,43 . However, amortization may be minimized by increasing the number of operations and by using some reusable devices for multiple operations 44–46 .…”

“… 40 , 41 Amortization of the robot console and costs involved with robot instrumentation are the major determinants of the incremental costs related to robotic surgery. 42 , 43 However, amortization may be minimized by increasing the number of operations and by using some reusable devices for multiple operations. 44 , 45 , 46 In addition, the significant decrease in complications and length of stay that we found in elderly patients with EC may also help to reduce the long‐term costs of robotic surgery.…”

Comparative Survival Outcome of Robot-Assisted Staging Surgery Using Three Robotic Arms versus Open Surgery for Endometrial Cancer

“…Open Surgery for Endometrial Cancer py 5,6,9 and laparoscopy with robot-assisted surgery exists, 10,11 along with a meta-analysis comparing all three approaches. 12,13 However, there is a scarcity of data with respect to direct comparison of survival outcomes between open surgery and RSS using three robotic arms for endometrial cancer.…”

Robot-assisted versus conventional laparoscopic surgery for endometrial cancer: long-term comparison of outcomes

“…However, there is a lack of large-volume, long-term follow-up data on the direct comparison of oncologic and surgical outcomes between RS and LS for the treatment of endometrial cancer. Currently, most reports suggest that short-term complication rates and survival outcomes for patients with endometrial cancer are similar between RS and LS ( 10 , 11 ).…”